(Q36273367)

13 August 2017

Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy (English)

1 reference

13 August 2017

0 references

anti-retroviral agent

0 references

0 references

1 reference

Anita Palepu

1

0 references

Mark W. Tyndall

Mark W Tyndall

2

0 references

Martin T. Schechter

Martin T Schechter

6

0 references

Robert S Hogg

Robert S Hogg

8

0 references

Julio Montaner

7

Julio S G Montaner

1 reference

13 August 2017

4

Benita Yip

1 reference

13 August 2017

Kathy Li

3

1 reference

PMCID

3456224

13 August 2017

Michael V O'Shaughnessy

5

1 reference

13 August 2017

1 December 2003

1 reference

13 August 2017

Journal of Urban Health

1 reference

13 August 2017

80

1 reference

13 August 2017

4

1 reference

13 August 2017

667-675

1 reference

https://scigraph.springernature.com/pub.10.1093/jurban/jtg073

13 August 2017

0 references

cites work

Human immunodeficiency virus in correctional facilities: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Jail inmates and HIV care: provision of antiretroviral therapy and Pneumocystis carinii pneumonia prophylaxis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Problem drinking and medication adherence among persons with HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Antiretroviral therapy for drug users

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Decreased methadone effect after ritonavir initiation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Prevalence and predictive value of intermittent viremia with combination hiv therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Barriers to use of free antiretroviral therapy in injection drug users.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456224

Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team

22 September 2018

1 reference

12 December 2020

Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART

1 reference

12 December 2020

Adherence to triple therapy and viral load response

1 reference

12 December 2020

Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women

1 reference

12 December 2020

Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients?

1 reference

12 December 2020

Antiretroviral prescribing patterns in the Texas prison system

1 reference

12 December 2020

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

1 reference

12 December 2020

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1093/JURBAN/JTG073

1 reference

PMCID

3456224

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

1 reference

PMCID

3456224